Clinical Trials
263 trialsNivolumab Combined With Ipilimumab Versus Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma (CheckMate 214)
Bristol-Myers Squibb
Combinations of Cemiplimab (Anti-PD-1 Antibody) and Platinum-based Doublet Chemotherapy in Patients With Lung Cancer
Regeneron Pharmaceuticals
Viale-a
AbbVie
POLARIX
Hoffmann-La Roche
NAVIGATE
Bayer
CodeBreak300
Amgen
(PATHFINDER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, in Patients With Advanced Systemic Mastocytosis
Blueprint Medicines Corporation
COMBI-AD
Novartis
FLAURA
AstraZeneca
NAPOLI 3
Ipsen
An Open-label Study of Encorafenib + Binimetinib in Patients With BRAFV600-mutant Non-small Cell Lung Cancer
Pfizer
KEYNOTE-966
Merck Sharp & Dohme LLC
Study of DS-1062a in Advanced or Metastatic Non-small Cell Lung Cancer With Actionable Genomic Alterations (TROPION-Lung05)
Daiichi Sankyo
MK-3475-775
Eisai Inc.
ZUMA-2
Gilead Sciences
PEARLS
Merck Sharp & Dohme LLC
Safety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal Melanoma
Immunocore Ltd
KEYNOTE-564
Merck Sharp & Dohme LLC
COLUMBUS
Pfizer
KEYNOTE-859
Merck Sharp & Dohme LLC
Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS
Gamida Cell ltd
innovaTV 301
Seagen Inc.
Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC)
Regeneron Pharmaceuticals
KEYNOTE-A18
Merck Sharp & Dohme LLC
MK-3475-204
Merck Sharp & Dohme LLC
ROSEWOOD
BeOne Medicines
CheckMate 648
Bristol-Myers Squibb
OlympiAD
AstraZeneca
Intergroup Randomized Trial for Children or Adolescents With B-Cell Non Hodgkin Lymphoma or B-Acute Leukemia: Rituximab Evaluation in High Risk Patients
Gustave Roussy, Cancer Campus, Grand Paris
IKEMA
Sanofi
A Study to Test the Safety of the Investigational Drug Larotrectinib in Adults That May Treat Cancer
Bayer
KEYNOTE-826
Merck Sharp & Dohme LLC
KEYNOTE-426
Merck Sharp & Dohme LLC
PROSPER
Pfizer
A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL
Eli Lilly and Company
DESTINY-CRC02
Daiichi Sankyo
A Study to Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301)
Astellas Pharma Inc
CheckMate 816
Bristol-Myers Squibb
CheckMate040
Bristol-Myers Squibb
ZUMA-5
Gilead Sciences
EMN14
European Myeloma Network B.V.
CheckMate 9LA
Bristol-Myers Squibb
Abatacept as GVHD Prophylaxis Phase 2
Boston Children's Hospital
MK-3475-811
Merck Sharp & Dohme LLC
A Study to Investigate Atezolizumab Subcutaneous in Patients With Previously Treated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Hoffmann-La Roche
A Study of ASP2215 Versus Salvage Chemotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-like Tyrosine Kinase (FLT3) Mutation
Astellas Pharma Inc
ARASENS
Bayer
APHINITY
Hoffmann-La Roche
A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic Amyloid Light-chain (AL) Amyloidosis
Janssen Research & Development, LLC
CheckMate 577
Bristol-Myers Squibb